KIMS
Krishna Institute of Medical Sciences Limited (KIMS) Stock Analysis
Krishna Institute of Medical Sciences Limited operates multi-specialty hospitals in Telangana and Andhra Pradesh. It provides tertiary care in oncology, cardiac, and surgical specialties. The company is expanding bed capacity and regional reach. It is a listed hospital chain.
Healthcare › Medical Care Facilities
₹685.60
-2.82% 1W | -4.30% 52W
Market Cap
28.8k CR
P/E Ratio
134.4
52W High
₹858
52W Low
₹575.8
Div. Yield
0%
Beta
0.3
50 DMA
₹763.9
200 DMA
₹725.3
Profit Margin
4.8%
Inst. Own.
41.2%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 606 | 652 | 606 | 634 | 688 | 777 | 772 | 797 | 872 | 961 | 998 | 1,075 | 1,180 |
| Expenses | 449 | 475 | 459 | 475 | 509 | 559 | 585 | 599 | 679 | 757 | 799 | 868 | 956 |
| Operating Profit | 157 | 177 | 147 | 159 | 179 | 218 | 187 | 198 | 193 | 204 | 199 | 206 | 223 |
| OPM % | 26% | 27% | 24% | 25% | 26% | 28% | 24% | 25% | 22% | 21% | 20% | 19% | 19% |
| Other Income | 3 | 3 | 3 | 4 | 5 | 5 | 18 | 15 | 7 | 4 | 5 | 1 | 17 |
| Interest | 9 | 9 | 12 | 16 | 18 | 20 | 26 | 27 | 33 | 45 | 57 | 68 | 83 |
| Depreciation | 32 | 33 | 35 | 46 | 39 | 41 | 45 | 53 | 53 | 66 | 79 | 85 | 101 |
| Profit before tax | 119 | 139 | 102 | 100 | 127 | 162 | 135 | 134 | 114 | 97 | 69 | 55 | 57 |
| Tax % | 27% | 27% | 25% | 28% | 25% | 26% | 31% | 21% | 25% | 26% | 24% | 40% | 34% |
| Net Profit | 87 | 101 | 77 | 72 | 95 | 121 | 92 | 106 | 85 | 72 | 52 | 33 | 37 |
| EPS in Rs | 2.02 | 2.30 | 1.80 | 1.64 | 2.16 | 2.68 | 2.22 | 2.54 | 1.96 | 1.67 | 1.33 | 1.06 | 0.99 |
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 512 | 567 | 664 | 918 | 1,123 | 1,330 | 1,651 | 2,198 | 2,498 | 3,035 | 3,905 | 4,212 |
| Expenses | 403 | 450 | 593 | 833 | 872 | 953 | 1,126 | 1,587 | 1,850 | 2,242 | 3,090 | 3,380 |
| Operating Profit | 109 | 118 | 71 | 85 | 251 | 377 | 524 | 611 | 648 | 793 | 815 | 833 |
| OPM % | 21% | 21% | 11% | 9% | 22% | 28% | 32% | 28% | 26% | 26% | 21% | 20% |
| Other Income | 5 | 3 | 37 | 6 | 5 | 9 | 27 | 41 | 13 | 43 | 17 | 28 |
| Interest | 37 | 32 | 88 | 49 | 44 | 37 | 22 | 37 | 55 | 100 | 215 | 253 |
| Depreciation | 36 | 35 | 40 | 56 | 71 | 70 | 73 | 129 | 147 | 177 | 283 | 331 |
| Profit before tax | 41 | 53 | -20 | -15 | 141 | 279 | 457 | 485 | 460 | 558 | 334 | 277 |
| Tax % | 32% | 37% | 126% | 223% | 18% | 26% | 25% | 25% | 27% | 26% | 28% | |
| Net Profit | 28 | 33 | -46 | -49 | 115 | 205 | 344 | 366 | 336 | 415 | 242 | 194 |
| EPS in Rs | 0.76 | 0.91 | -1.32 | -1.28 | 3.20 | 5.19 | 8.32 | 8.41 | 7.75 | 9.61 | 6.03 | 5.05 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 21.0% | 24.0% | 23.0% |
| Profit CAGR | -9.0% | 4.0% | 25.0% |
Shareholding Pattern
Promoters34.11%
FIIs15.54%
DIIs31.65%
Public18.68%
Promoters34.11%
FIIs15.03%
DIIs32.12%
Public18.74%
Promoters34.11%
FIIs14.33%
DIIs32.72%
Public18.85%
Promoters34.11%
FIIs14.57%
DIIs32.50%
Public18.82%
Promoters32.49%
FIIs14.75%
DIIs34.42%
Public18.32%
Promoters38.85%
FIIs19.41%
DIIs29.76%
Public11.99%
Promoters38.82%
FIIs16.73%
DIIs33.13%
Public11.32%
Promoters38.82%
FIIs15.44%
DIIs31.95%
Public13.78%
Promoters34.11%
FIIs14.57%
DIIs32.50%
Public18.82%
Promoters32.49%
FIIs14.75%
DIIs34.42%
Public18.32%
KIMS
Holdings Analysis
Key strengths & risk signals
58
Overall
63
Fundamental
54
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
WEAK POSITION! Current price (685.6) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 2.8% (1 week), 10.6% (1 month), 14.6% (3 months).
WEAK YEAR! Stock declined 4.3% in the last year.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (763.9) is above 200-day average (725.3) - positive signal.
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
APPROACHING OVERSOLD! RSI at 30.6 - watch for reversal.
Fundamental & Technical Analysis
58Overall
63Fundamental
54Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 21.3% (EXCELLENT, 15/15). Profit CAGR: -10.5% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 4.8% profit margin - thin profits.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
20/20
VERY LESS PUBLIC HOLDING! 12.23% public ownership - strong promoter/institutional control.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (763.9) is above 200-day average (725.3) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (685.6) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
3/10
WEAK YEAR! Stock declined 4.3% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 12 up days, 18 down days. Avg volume on up days: 492,742 vs down days: 534,124. Ratio: 0.92x
RSI
4/5
APPROACHING OVERSOLD! RSI at 30.6 - watch for reversal.
52W Range
2/5
LOWER HALF! Trading at 38.9% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 2.8% (1 week), 10.6% (1 month), 14.6% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
KIMS
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-08 | Concall PDF | |
| Q4FY262026-05-22 | Concall PDF | |
| Q3FY262026-02-13 | Concall PDF | |
| Q2FY262025-11-14 | Concall PDF |
Peer Comparison
Healthcare · Medical Care Facilities · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| KIMS | ₹685.60 | 134.4 | 4.8% | 21.3% | -10.5% | -4.3% | 58 | BREAKDOWN | -47.2% | -2.4% | +35.3% | +9.8% |
| MEDANTA | ₹1,240.00 | 60 | 11.9% | 17.2% | 19.5% | -6.7% | 64 | BREAKDOWN | -0.2% | +10.2% | +26.5% | +12.5% |
| NH | ₹1,719.40 | 42.5 | 9.0% | 20.5% | 9.9% | -3.8% | 59 | APPROACHING SUPPORT | +5.3% | -7.5% | +78.0% | +3.5% |
| FORTIS | ₹736.50 | 53.1 | 11.0% | 13.3% | 21.0% | -31.2% | 61 | BREAKDOWN | +2.3% | +0.2% | +17.5% | +7.6% |
| ASTERDM | ₹674.40 | 109.3 | 6.5% | 15.7% | -3.0% | -2.8% | 56 | BREAKDOWN | -81.2% | -88.5% | +21.6% | +10.9% |
| MAXHEALTH | ₹846.00 | 56.7 | 16.7% | 22.4% | 9.3% | -28.7% | 55 | BREAKDOWN | +4.9% | -5.6% | +16.7% | +10.4% |
| APOLLOHOSP | ₹7,890.00 | 54.3 | 7.9% | 14.8% | 33.3% | -0.2% | 63 | BREAKDOWN | +34.2% | +9.7% | +20.6% | +6.6% |
| RAINBOW | ₹1,248.90 | 44.4 | 15.7% | 13.1% | 9.7% | -7.6% | 64 | BOUNCE FROM SUPPORT | +13.3% | -21.3% | +33.2% | +2.2% |
Data from TradeAlone · Updated daily
